Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01767623
Title A Study of The Impact of Severe Hepatic Impairment on the Pharmacokinetics and Safety of Vemurafenib in BRAF V600 Mutation-Positive Cancer Patients
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult
Covered Countries USA | TUR | ISR | GRC | GBR | AUS

Facility Status City State Zip Country Details
California Cancer Associates for Research & Excellence, Inc. Encinitas California 92008 United States Details
Peninsula and South Eastern Haematology and Oncology Grou Frankston Victoria 3199 Australia Details
District General Hospital of Athens Laiko; 1st Internal Medicine Clinic Athens 11527 Greece Details
Rambam Health Care Campus Haifa 31096 Israel Details
Tel Aviv Sourasky Medical Center Tel Aviv 64239 Israel Details
SBIH " Clinical Oncological Dispensary # 1"; Chemotherapy department #1 and #2 Krasnodar 350040 Russian Federation Details
Ege University Medicine Develoment and Pharmacokinetics Research Center; Pulmonary Diseases Izmir 35040 Turkey Details
Velindre Cancer Centre Cardiff CF14 2TL United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field